HIV Medicine

Article	Citations
	111
Issue Information	83
	79
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	55
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	53
	51
The characteristics of men who have sex with men (MSM) using post‐exposure prophylaxis for sexual exposure (PEPSE) in the pre‐exposure prophylaxis (PrEP) era	43
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	42
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	40
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	36
Issue Information	34
Reflections on a specialist HIV menopause service	33
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	32
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	30
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	28
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	28
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study	24
Aetiology of fever of unknown origin in people living with HIV: A systematic review and meta‐analysis	24
Cellular and humoral response after mRNA SARS‐CoV‐2 vaccination in kidney transplant recipients living with HIV: A cross‐sectional study	23
Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy	22
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	22
HIV cure: Are we going to make history?	21
	20
Issue Information	20
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024	19

Influence of physical activity on endothelial function in people living with HIV	19
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	19
Issue Information	17
Using an automated decision support tool to improve HIV prescribing: A feasibility study	17
The value of herpes zoster prevention in people aging with HIV: A narrative review	16
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	16
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	15
Dual drivers of polypharmacy in people with HIV: Quantifying the independent associations of aging and long‐term antiretroviral therapy	15
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	15
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)	15
Changing prevalence and risk factors for Toxoplasma gondii seropositivity and disease in persons with HIV at the Southern Alberta Clinic since 1985	15
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	14
Issue Information	14
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	14
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care	14
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	14
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study	14
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	14
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy	14
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis	13
	12
	12
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process	12
Special issue on Women and HIV to mark International Women’s Day	12
	12
HIV‐associated thrombotic thrombocytopenic purpura (HIV‐TTP): A practical guide and review of the literature	12
Gender equality in leadership of HIV care cascade clinical trials: A methodological study	11
Microbial translocation is associated with advanced liver fibrosis among people with HIV	11
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis	11
Issue Information	11
Response to letter by Kumar et al. on “Exploring the cascade of mental health care among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY	11
Issue Information	11
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia	10
AI in medicine: No longer the future, but the present	10
	10
Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: A prospective cohort study	10
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4	10
	10
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies	10
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments	10
“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”	10
	10
Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individual	10
Oral Abstracts	9
Late diagnosis of human immunodeficiency virus (HIV) and its associated factors in Asian countries: A systematic review	9
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study	9
Index	9
HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)	9
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy	9
Knowledge and HIV‐related stigma among Portuguese healthcare professionals: A cross‐sectional analysis	9

Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project	9
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection	9
Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care	9
Blood pressure and metabolic outcomes after efavirenz‐ or dolutegravir‐based therapy started in acute HIV infection	9
	8
Issue Information	8
Virtual care pathways for people living with HIV: A mixed‐methods systematic review	8
Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors	8
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature rev	8
Author Index	8
The role of HIV as a risk modifier for coronary endothelial function in young adults	8
Author Index	8
Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV	8
Polypharmacy in HIV : Rethinking what counts and why it matters	8
Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV	7
Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases	7
Issue Information	7
Spatial and temporal trends in HIV/AIDS burden among South Asian countries from 1990 to 2021: A systematic examination of the Global Burden of Disease study 2021	7
Anticholinergic medications associated with falls and frailty in people with HIV	7
Examination of factors associated with mental health of people living with HIV in Kazakhstan: A cross‐sectional study based on the two‐continua model	7
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV‐1 vaccine formulations	7
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals	7
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study	7
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV	7
Immune response to ART initiation in advanced HIV infection	7
Late diagnosis of HIV: An updated consensus definition	7
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)	7
Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda	7
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review	7
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV	7
Cardiovascular risk knowledge stratified by predicted cardiovascular risk level among people living with HIV attending a tertiary HIV care centre in Gaborone, Botswana: A cross‐s	7
Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable	7
Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak	7
Incidence and predictors of attrition from HIV treatment among adults living with HIV in high‐caseload facilities following implementation of universal test and treat strategy in	7
Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study	7
“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spa	7
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	6
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	6
Implementation of frailty screening for older people living with HIV in Brighton, UK	6
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use	6
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey	6
Issue Information	6
CROI 2024 BHIVA working group summary	6
	6
Sexual dysfunction care needs of gay, bisexual, and other men who have sex with men living with HIV in Montreal, Canada	6
Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
Issue Information	6
British HIV Association guidelines for the management of HIV‐2 2021	6
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	6
Positive Outcomes: Validity, reliability and responsiveness of a novel person‐centred outcome measure for people with HIV	6
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	6
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study	6
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment	6
Issue Information	5
Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	5
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study	5
Clinical outcomes of HIV–syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study	5
Issue Information	5
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	5
Perceived disabling physical pain and suicidal ideation in aging people living with HIV cured of hepatitis C: A multi‐center survey in France (ANRS CO13 HEPAVIH)	5
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey	5
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression	5
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III stud	5
	5
Correction to ‘Abstracts of the 19th European AIDS Conference (#EACS2023), October 18–21, 2023, Warsaw, Poland’	5
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with	5
Real‐world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV‐1 sub‐subtype A6 harbouring the L74I mutation	5
	5
Issue Information	5
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV services	5
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	5
Issue Information	5
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series	5
Natural occurrence of drug resistance mutations to the HIV‐1 capsid inhibitor lenacapavir	5
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta‐analysis	5
Factors influencing the quality of life and social skills of children living with HIV: A case–control study	5
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV	5
	5

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence	5
Longitudinal analysis of new‐onset non‐AIDS‐defining diseases among people living with HIV: A real‐world observational study	5
Issue Information	5
Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic rand	5
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study	5
Frailty in people 50 years or older living with HIV: A sex perspective	4
	4
PrEP for women in Europe: a systematic literature review	4
	4
Issue Information	4
Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms	4
	4
Rapid HIV pre‐exposure prophylaxis (PrEP) initiation is safe and feasible: Experience from Wroclaw All Saints cohort in Poland 2017–2021	4
	4
Issue Information	4
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts	4
EACS Abstract 2025	4
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region	4
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)	4
Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population‐based cohort study	4
Late diagnosis of HIV in 2022: Why so little change?	4
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region	4
	4
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96	4
	4
Antiretroviral drug switches to zidovudine‐based regimens and loss to follow‐up during the first COVID‐19 lockdown in Bali, Indonesia	4
Erratum	4
	4
Comorbidities, comedications and potential drug–drug interactions among people living with HIV in China	4
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies	4
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025	4
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems	4
HIV and fracture: Risk, assessment and intervention	4
Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial	4
Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV‐1 in Türkiye	4
Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV	4
	4
	4
Issue Information	4
Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020	4
Issue Information	4
The spectrum of kidney biopsy findings in Chinese HIV‐infected patients	4
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial	4